Cytiva pledges $52.5M into South Korean operations as it expands global plans
When Cytiva decided it would play a role in the Covid-19 pandemic, it moved quickly to open new manufacturing sites and adapt existing ones. Now, the company will send that investment overseas as the company announced a multimillion-dollar memorandum of understanding with South Korea last week.
South Korean President Moon Jae-in was present for the announcement, which took place at a New York ceremony. Cytiva has pledged $52.5 million in South Korea for the next two years, starting in 2022, Moon said.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,700+ biopharma pros reading Endpoints daily — and it's free.